Kids in the United States will likely be able to get Covid-19 vaccinations by the end of 2021 or the first quarter of 2022, Dr. Anthony Fauci, the nation’s top infectious disease expert, said at an event on May 19.
The Covid-19 epidemic highlighted the disproportionate way the virus impacted minority communities across the U.S., increasing the calls for racial and ethnic diversity in clinical studies. While there has been a more significant push, a recent Pfizer clinical trials diversity report shows there is still a wide gap that needs to be bridged.
Covid-19 vaccine developers are making ever bolder assertions that the world will need yearly booster shots, or new vaccines to tackle concerning coronavirus variants, but some scientists question when, or whether, such shots will be needed.
U.S. states are set to begin using the vaccine from Pfizer Inc. and BioNTech SE to inoculate young adolescents against Covid-19 after advisers to the U.S. Centers for Disease Control and Prevention (CDC) backed the plan in a unanimous vote on May 12.
Advisors to the U.S. Centers for Disease Control and Prevention (CDC) will meet on May 12 to discuss recommendations for the use of Pfizer and partner BioNTech’s Covid-19 vaccine in children aged 12 to 15.
Samsung BioLogics Co. Ltd. and Pfizer Inc. on May 12 denied a report that they were working together to produce in South Korea a Covid-19 vaccine developed by the U.S. drugmaker.
U.S. regulators on May 10 authorized Pfizer and BioNTech’s Covid-19 vaccine for use in children as young as 12 years and said they could begin receiving shots as soon as May 11, widening the country’s inoculation program as vaccination rates have slowed significantly.
Pfizer Inc. and the company’s German partner BioNTech SE said on May 6 they would donate doses of their Covid-19 vaccine to help vaccinate athletes and their delegations participating in the Tokyo Olympic and Paralympic Games.
President Joe Biden on May 5 threw his support behind waiving intellectual property rights for Covid-19 vaccines, bowing to mounting pressure from Democratic lawmakers and more than 100 other countries, but angering pharmaceutical companies. Biden voiced his support for a waiver – a sharp reversal of the previous U.S. position – in remarks to reporters, followed swiftly by a statement from his top trade negotiator, Katherine Tai, who backed negotiations at the World Trade Organization.
Pfizer reported first-quarter 2021 revenue of $14.6 billion, an impressive 42 percent operational growth. The company’s Covid-19 vaccine revenue accounted for $3.5 billion of the total.